C71T
CANCELLED SECTION 71
05/06/2026
Voltar para busca
Dado oficial do USPTO
UROVANT SCIENCES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
57
Atualização mais recente
30/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
24/10/2018
Data de registro
19/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/06/2026
Última transação
30/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
27
Localização do titular
CH
Examinador
WRIGHT, MARCO JABBAR
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "UROVANT" in blue with a green stylized leaf integrated into letter "A" all above the word "SCIENCES" in green.
Titulares e representantes
Titulares
Urovant Sciences GmbH
Representantes
Jeffrey R. Cadwell Dorsey & Whitney LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for human use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for human use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Biologic preparations for medical and therapeutic purposes for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Biologic preparations for medical and therapeutic purposes for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders
Classe 42
Scientific and technological services as well as research and design services relating thereto, namely, technical research in the fields of pharmaceuticals, medical devices and biological studies; biomedical and pharmaceutical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
Classe 44
Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Publicações
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/03/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
19/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
12/04/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
12/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/04/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
08/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/04/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/02/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/03/2020
FIMP
FINAL DISPOSITION PROCESSED
09/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/02/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
19/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2019
PUBO
PUBLISHED FOR OPPOSITION
03/09/2019
GPNX
NOTIFICATION PROCESSED BY IB
30/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/08/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/08/2019
ALIE
ASSIGNED TO LIE
30/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/07/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
22/07/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/07/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
22/07/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/06/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/04/2019
RFNT
REFUSAL PROCESSED BY IB
02/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/02/2019
RFRR
REFUSAL PROCESSED BY MPU
09/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/02/2019
CNRT
NON-FINAL ACTION WRITTEN
31/01/2019
DOCK
ASSIGNED TO EXAMINER
31/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UROVANT SCIENCES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.